Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Syk inhibitors(Spleen tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24N6O |
InChIKeyNZNTWOVDIXCHHS-LSDHHAIUSA-N |
CAS Registry1194961-19-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heparin-induced thrombocytopenia | Preclinical | US | 17 Feb 2011 |